Jeremie Guedj (Jérémie Guedj)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 41

Top Topics

Antiretroviral Therapy

Top Venues

Nature communications

CPT: pharmacometrics & systems pharmacology

PLoS computational biology

Clinical pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Caroline Passaes, Delphine Desjardins, Anaïs Chapel, Valérie Monceaux, Julien Lemaitre, Adeline Mélard, Federico Perdomo-Celis, Cyril Planchais, Maël Gourvès, Nastasia Dimant, Annie David, Nathalie Bosquet, Aurélie Barrail-Tran, Hélène Gouget, Céline Guillaume, Francis Relouzat, Olivier Lambotte, Jeremie Guedj, Michaela Müller-Trutwin, Hugo Mouquet, Christine Rouzioux, Veronique Avettand-Fenoel, Roger Le Grand, Asier Sáez-Cirión
Early antiretroviral therapy favors post-treatment SIV control associated with the expansion of enhanced memory CD8 + T-cells. Nature communications 15 (1) (2024)
Caroline Passaes, Delphine Desjardins, Anaïs Chapel, Valérie Monceaux, Julien Lemaitre, Adeline Mélard, Federico Perdomo-Celis, Cyril Planchais, Maël Gourvès, Nastasia Dimant, Annie David, Nathalie Bosquet, Aurélie Barrail-Tran, Hélène Gouget, Céline Guillaume, Francis Relouzat, Olivier Lambotte, Jeremie Guedj, Michaela Müller-Trutwin, Hugo Mouquet, Christine Rouzioux, Veronique Avettand-Fenoel, Roger Le Grand, Asier Sáez-Cirión
Early antiretroviral therapy favors post-treatment SIV control associated with the expansion of enhanced memory CD8 + T-cells. Nature communications 15 (1) (2024)
Caroline Passaes, Delphine Desjardins, Anaïs Chapel, Valérie Monceaux, Julien Lemaitre, Adeline Mélard, Federico Perdomo-Celis, Cyril Planchais, Maël Gourvès, Nastasia Dimant, Annie David, Nathalie Bosquet, Aurélie Barrail-Tran, Hélène Gouget, Céline Guillaume, Francis Relouzat, Olivier Lambotte, Jeremie Guedj, Michaela Müller-Trutwin, Hugo Mouquet, Christine Rouzioux, Veronique Avettand-Fenoel, Roger Le Grand, Asier Sáez-Cirión
Early antiretroviral therapy favors post-treatment SIV control associated with the expansion of enhanced memory CD8 + T-cells. Nature communications 15 (1) (2024)
Caroline Passaes, Delphine Desjardins, Anaïs Chapel, Valérie Monceaux, Julien Lemaitre, Adeline Mélard, Federico Perdomo-Celis, Cyril Planchais, Maël Gourvès, Nastasia Dimant, Annie David, Nathalie Bosquet, Aurélie Barrail-Tran, Hélène Gouget, Céline Guillaume, Francis Relouzat, Olivier Lambotte, Jeremie Guedj, Michaela Müller-Trutwin, Hugo Mouquet, Christine Rouzioux, Veronique Avettand-Fenoel, Roger Le Grand, Asier Sáez-Cirión
Early antiretroviral therapy favors post-treatment SIV control associated with the expansion of enhanced memory CD8 + T-cells. Nature communications 15 (1) (2024)
Mathilde Marchand, Antonio Gonçalves, Francois Mercier, Pascal Chanu, Jin Yan Jin, Jeremie Guedj, René Bruno
Tumor growth and overall survival modeling to support decision making in phase Ib/II trials: A comparison of the joint and two-stage approaches. CPT: pharmacometrics & systems pharmacology 13 (6) (2024)
Caroline Passaes, Delphine Desjardins, Anaïs Chapel, Valérie Monceaux, Julien Lemaitre, Adeline Mélard, Federico Perdomo-Celis, Cyril Planchais, Maël Gourvès, Nastasia Dimant, Annie David, Nathalie Bosquet, Aurélie Barrail-Tran, Hélène Gouget, Céline Guillaume, Francis Relouzat, Olivier Lambotte, Jeremie Guedj, Michaela Müller-Trutwin, Hugo Mouquet, Christine Rouzioux, Veronique Avettand-Fenoel, Roger Le Grand, Asier Sáez-Cirión
Early antiretroviral therapy favors post-treatment SIV control associated with the expansion of enhanced memory CD8 + T-cells. Nature communications 15 (1) (2024)
Maxime Beaulieu, Alexandre Gaymard, Clément Massonnaud, Nathan Peiffer Smadja, Maude Bouscambert-Duchamp, Guislaine Carcelain, Guillaume Lingas, France Mentré, Florence Ader, Maya Hites, Pascal Poignard, Jeremie Guedj
Antiviral effect of Evusheld in COVID-19 hospitalized patients infected with pre-Omicron or Omicron variants: a modelling analysis of the randomized DisCoVeRy trial. The Journal of antimicrobial chemotherapy (2024)
Mathilde Marchand, Antonio Gonçalves, Francois Mercier, Pascal Chanu, Jin Yan Jin, Jeremie Guedj, René Bruno
Tumor growth and overall survival modeling to support decision making in phase Ib/II trials: A comparison of the joint and two-stage approaches. CPT: pharmacometrics & systems pharmacology (2024)
Caroline Passaes, Delphine Desjardins, Anaïs Chapel, Valérie Monceaux, Julien Lemaitre, Adeline Mélard, Federico Perdomo-Celis, Cyril Planchais, Maël Gourvès, Nastasia Dimant, Annie David, Nathalie Bosquet, Aurélie Barrail-Tran, Hélène Gouget, Céline Guillaume, Francis Relouzat, Olivier Lambotte, Jeremie Guedj, Michaela Müller-Trutwin, Hugo Mouquet, Christine Rouzioux, Veronique Avettand-Fenoel, Roger Le Grand, Asier Sáez-Cirión
Early antiretroviral therapy favors post-treatment SIV control associated with the expansion of enhanced memory CD8 + T-cells. Nature communications 15 (1) (2024)
Mathilde Marchand, Antonio Gonçalves, Francois Mercier, Pascal Chanu, Jin Yan Jin, Jeremie Guedj, René Bruno
Tumor growth and overall survival modeling to support decision making in phase Ib/II trials: A comparison of the joint and two-stage approaches. CPT: pharmacometrics & systems pharmacology 13 (6) (2024)
Mathilde Marchand, Antonio Gonçalves, Francois Mercier, Pascal Chanu, Jin Yan Jin, Jeremie Guedj, René Bruno
Tumor growth and overall survival modeling to support decision making in phase Ib/II trials: A comparison of the joint and two-stage approaches. CPT: pharmacometrics & systems pharmacology 13 (6) (2024)
Marion Kerioui, Julie Bertrand, Solène Desmée, Christophe Le Tourneau, Francois Mercier, René Bruno, Jeremie Guedj
Assessing the Increased Variability in Individual Lesion Kinetics During Immunotherapy: Does It Exist, and Does It Matter? JCO precision oncology 7 (2023)
Aurélien Marc, Romain Marlin, Flora Donati, Mélanie Prague, Marion Kerioui, Cécile Hérate, Marie Alexandre, Nathalie Dereuddre-Bosquet, Julie Bertrand, Vanessa Contreras, Sylvie Behillil, Pauline Maisonnasse, Sylvie Van Der Werf, Roger Le Grand, Jeremie Guedj
Impact of variants of concern on SARS-CoV-2 viral dynamics in non-human primates. PLoS computational biology 19 (8) (2023)
Quentin Clairon, Mélanie Prague, Delphine Planas, Timothée Bruel, Laurent Hocqueloux, Thierry Prazuck, Olivier Schwartz, Rodolphe Thiebaut, Jeremie Guedj
Modeling the kinetics of the neutralizing antibody response against SARS-CoV-2 variants after several administrations of Bnt162b2. PLoS computational biology 19 (8) (2023)
Guillaume Lingas, Delphine Planas, Hélène Péré, Françoise Porrot, Florence Guivel-Benhassine, Isabelle Staropoli, Darragh Duffy, Nicolas Chapuis, Camille Gobeaux, David Veyer, Constance Delaugerre, Jérôme Le Goff, Prunelle Getten, Jérôme Hadjadj, Adèle Bellino, Béatrice Parfait, Jean-Marc Treluyer, Olivier Schwartz, Jeremie Guedj, Solen Kernéis, Benjamin Terrier
Neutralizing antibody levels as a correlate of protection against SARS-CoV-2 infection: a modeling analysis. Clinical pharmacology and therapeutics (2023)
Antonio Gonçalves, Mathilde Marchand, Phyllis Chan, Jin Yan Jin, Jeremie Guedj, René Bruno
Comparison of two-stage and joint TGI-OS modeling using data from six atezolizumab clinical studies in patients with metastatic non-small cell lung cancer. CPT: pharmacometrics & systems pharmacology (2023)
Marion Kerioui, Julie Bertrand, Solène Desmée, Christophe Le Tourneau, Francois Mercier, René Bruno, Jeremie Guedj
Assessing the Increased Variability in Individual Lesion Kinetics During Immunotherapy: Does It Exist, and Does It Matter? JCO precision oncology 7 (2023)
Nadège Néant, Guillaume Lingas, Alexandre Gaymard, Drifa Belhadi, Maya Hites, Thérèse Staub, Richard Greil, Jose-Artur Paiva, Julien Poissy, Nathan Peiffer-Smadja, Dominique Costagliola, Yazdan Yazdanpanah, Maude Bouscambert-Duchamp, Amandine Gagneux-Brunon, Florence Ader, France Mentré, Florent Wallet, Charles Burdet, Jeremie Guedj, null null
Association between SARS-CoV-2 viral kinetics and clinical score evolution in hospitalized patients. CPT: pharmacometrics & systems pharmacology (2023)
Romain Marlin, Delphine Desjardins, Vanessa Contreras, Guillaume Lingas, Caroline Solas, Pierre Roques, Thibaut Naninck, Quentin Pascal, Sylvie Behillil, Pauline Maisonnasse, Julien Lemaitre, Nidhal Kahlaoui, Benoit Delache, Andrés Pizzorno, Antoine Nougairède, Camille Ludot, Olivier Terrier, Nathalie Bosquet, Francis Relouzat, Catherine Chapon, Raphael Ho Tsong Fang, Sylvie van der Werf, Manuel Rosa Calatrava, Denis Malvy, Xavier Nicolas de Lamballerie, Jeremie Guedj, Roger Le Grand
Antiviral efficacy of favipiravir against Zika and SARS-CoV-2 viruses in non-human primates. Nature communications 13 (1) (2022)
Jinju Guk, Antoine Bridier-Nahmias, Mélanie Magnan, Nathalie Grall, Xavier Duval, Olivier Clermont, Etienne Ruppé, Camille d'Humières, Olivier Tenaillon, Erick Denamur, France Mentré, Jeremie Guedj, Charles Burdet, null null
Modeling the bacterial dynamics in the gut microbiota following an antibiotic-induced perturbation. CPT: pharmacometrics & systems pharmacology 11 (7) (2022)
Guillaume Lingas, Nadège Néant, Alexandre Gaymard, Drifa Belhadi, Gilles Peytavin, Maya Hites, Thérèse Staub, Richard Greil, Jose-Artur Paiva, Julien Poissy, Nathan Peiffer Smadja, Dominique Costagliola, Yazdan Yazdanpanah, Florent Wallet, Amandine Gagneux-Brunon, France Mentré, Florence Ader, Charles Burdet, Jeremie Guedj, Maude Bouscambert-Duchamp
Effect of remdesivir on viral dynamics in COVID-19 hospitalized patients: a modelling analysis of the randomized, controlled, open-label DisCoVeRy trial. The Journal of antimicrobial chemotherapy 77 (5) (2022)
Selma El Messaoudi, Annabelle Lemenuel-Diot, Antonio Gonçalves, Jeremie Guedj
A semi-mechanistic model to characterize the long-term dynamic of HBV markers during treatment with lamivudine and Peg-IFN. Clinical pharmacology and therapeutics (2022)
Baptiste Elie, Bénédicte Roquebert, Mircea T Sofonea, Sabine Trombert-Paolantoni, Vincent Foulongne, Jeremie Guedj, Stpéhanie Haim-Boukobza, Samuel Alizon
Variant-specific SARS-CoV-2 within-host kinetics. Journal of medical virology 94 (8) (2022)
Stéphanie Reynard, Emilie Gloaguen, Nicolas Baillet, Vincent Madelain, Jeremie Guedj, Hervé Raoul, Xavier de Lamballerie, Jimmy Mullaert, Sylvain Baize
Early control of viral load by favipiravir promotes survival to Ebola virus challenge and prevents cytokine storm in non-human primates. PLoS neglected tropical diseases 15 (3) (2021)
Nadège Néant, Guillaume Lingas, Quentin Le Hingrat, Jade Ghosn, Ilka Engelmann, Quentin Lepiller, Alexandre Gaymard, Virginie Ferré, Cédric Hartard, Jean-Christophe Plantier, Vincent Thibault, Julien Marlet, Brigitte Montes, Kevin Bouiller, François-Xavier Lescure, Jean François Timsit, Emmanuel Faure, Julien Poissy, Christian Chidiac, François Raffi, Antoine Kimmoun, Manuel Etienne, Jean-Christophe Richard, Pierre Tattevin, Denis Garot, Vincent Le Moing, Delphine Bachelet, Coralie Tardivon, Xavier Duval, Yazdan Yazdanpanah, France Mentré, Cédric Laouénan, Benoit Visseaux, Jeremie Guedj, null null
Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort. Proceedings of the National Academy of Sciences of the United States of America 118 (8) (2021)
Guillaume Lingas, Kyle Rosenke, David Safronetz, Jeremie Guedj
Lassa viral dynamics in non-human primates treated with favipiravir or ribavirin. PLoS computational biology 17 (1) (2021)
Peter Czuppon, Florence Débarre, Antonio Gonçalves, Olivier Tenaillon, Alan S Perelson, Jeremie Guedj, François Blanquart
Success of prophylactic antiviral therapy for SARS-CoV-2: Predicted critical efficacies and impact of different drug-specific mechanisms of action. PLoS computational biology 17 (3) (2021)
Katharine Best, Dan H Barouch, Jeremie Guedj, Ruy M Ribeiro, Alan S Perelson
Zika virus dynamics: Effects of inoculum dose, the innate immune response and viral interference. PLoS computational biology 17 (1) (2021)
Aurélien Marc, Marion Kerioui, François Blanquart, Julie Bertrand, Oriol Mitjà, Marc Corbacho-Monné, Michael Marks, Jeremie Guedj
Quantifying the relationship between SARS-CoV-2 viral load and infectiousness. eLife 10 (2021)
Pauline Maisonnasse, Yoann Aldon, Aurélien Marc, Romain Marlin, Nathalie Bosquet, Natalia A Kuzmina, Alec W Freyn, Jonne L Snitselaar, Antonio Gonçalves, Tom G Caniels, Judith A Burger, Meliawati Poniman, Ilja Bontjer, Virginie Chesnais, Ségolène Diry, Anton Iershov, Adam J Ronk, Sonia Jangra, Raveen Rathnasinghe, Philip J M Brouwer, Tom P L Bijl, Jelle van Schooten, Mitch Brinkkemper, Hejun Liu, Meng Yuan, Chad E Mire, Mariëlle J van Breemen, Vanessa Contreras, Thibaut Naninck, Julien Lemaître, Nidhal Kahlaoui, Francis Relouzat, Catherine Chapon, Raphaël Ho Tsong Fang, Charlene McDanal, Mary Osei-Twum, Natalie St-Amant, Luc Gagnon, David C Montefiori, Ian A Wilson, Eric Ginoux, Godelieve J de Bree, Adolfo García-Sastre, Michael Schotsaert, Lynda Coughlan, Alexander Bukreyev, Sylvie van der Werf, Jeremie Guedj, Rogier W Sanders, Marit J van Gils, Roger Le Grand
COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models. Nature communications 12 (1) (2021)
Antonio Gonçalves, Pauline Maisonnasse, Flora Donati, Mélanie Albert, Sylvie Behillil, Vanessa Contreras, Thibaut Naninck, Romain Marlin, Caroline Solas, Andrés Pizzorno, Julien Lemaitre, Nidhal Kahlaoui, Olivier Terrier, Raphael Ho Tsong Fang, Vincent Enouf, Nathalie Dereuddre-Bosquet, Angela Brisebarre, Franck Touret, Catherine Chapon, Bruno Hoen, Bruno Lina, Manuel Rosa Calatrava, Xavier Nicolas de Lamballerie, France Mentré, Roger Le Grand, Sylvie van der Werf, Jeremie Guedj
SARS-CoV-2 viral dynamics in non-human primates. PLoS computational biology 17 (3) (2021)
Jean-Sélim Driouich, Maxime Cochin, Guillaume Lingas, Grégory Moureau, Franck Touret, Paul-Rémi Petit, Géraldine Piorkowski, Karine Barthélémy, Caroline Laprie, Bruno Coutard, Jeremie Guedj, Xavier Nicolas de Lamballerie, Caroline Solas, Antoine Nougairède
Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model. Nature communications 12 (1) (2021)
Jinju Guk, Jeremie Guedj, Charles Burdet, Antoine Andremont, Jean de Gunzburg, Annie Ducher, France Mentré
Modeling the Effect of DAV132, a Novel Colon-Targeted Adsorbent, on Fecal Concentrations of Moxifloxacin and Gut Microbiota Diversity in Healthy Volunteers. Clinical pharmacology and therapeutics 109 (4) (2020)
Pauline Maisonnasse, Jeremie Guedj, Vanessa Contreras, Sylvie Behillil, Caroline Solas, Romain Marlin, Thibaut Naninck, Andres Pizzorno, Julien Lemaitre, Antonio Gonçalves, Nidhal Kahlaoui, Olivier Terrier, Raphael Ho Tsong Fang, Vincent Enouf, Nathalie Bosquet, Angela Brisebarre, Franck Touret, Catherine Chapon, Bruno Hoen, Bruno Lina, Manuel Rosa Calatrava, Sylvie van der Werf, Xavier de Lamballerie, Roger Le Grand
Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates. Nature 585 (7826) (2020)
Coralie Tardivon, Solène Desmée, Marion Kerioui, René Bruno, Benjamin Wu, France Mentré, Francois Mercier, Jeremie Guedj
Association Between Tumor Size Kinetics and Survival in Patients With Urothelial Carcinoma Treated With Atezolizumab: Implication for Patient Follow-Up. Clinical pharmacology and therapeutics 106 (4) (2019)
Jeremie Guedj, Géraldine Piorkowski, Frédéric Jacquot, Vincent Madelain, Thi Huyen Tram Nguyen, Anne Rodallec, Stephan Gunther, Caroline Carbonnelle, France Mentré, Hervé Raoul, Xavier de Lamballerie
Antiviral efficacy of favipiravir against Ebola virus: A translational study in cynomolgus macaques. PLoS medicine 15 (3) (2018)
Vincent Madelain, Sylvain Baize, Frédéric Jacquot, Stéphanie Reynard, Alexandra Fizet, Stephane Barron, Caroline Solas, Bruno Lacarelle, Caroline Carbonnelle, France Mentré, Hervé Raoul, Xavier Nicolas de Lamballerie, Jeremie Guedj
Ebola viral dynamics in nonhuman primates provides insights into virus immuno-pathogenesis and antiviral strategies. Nature communications 9 (1) (2018)
Sophie J Rhodes, Jeremie Guedj, Helen A Fletcher, Thomas Lindenstrøm, Thomas J Scriba, Thomas G Evans, Gwenan M Knight, Richard G White
Using vaccine Immunostimulation/Immunodynamic modelling methods to inform vaccine dose decision-making. NPJ vaccines 3 (2018)
Paola Carrillo-Bustamante, Thi Huyen Tram Nguyen, Lisa Oestereich, Stephan Günther, Jeremie Guedj, Frederik Graw
Determining Ribavirin's mechanism of action against Lassa virus infection. Scientific reports 7 (1) (2017)
Thi Huyen Tram Nguyen, Jeremie Guedj, Susan L Uprichard, Anita Kohli, Shyam Kottilil, Alan S Perelson
The paradox of highly effective sofosbuvir-based combination therapy despite slow viral decline: can we still rely on viral kinetics? Scientific reports 7 (1) (2017)
Thi Huyen Tram Nguyen, Jeremie Guedj, Xavier Anglaret, Cédric Laouénan, Vincent Madelain, Anne-Marie Taburet, Sylvain Baize, Daouda Sissoko, Boris Pastorino, Anne Rodallec, Géraldine Piorkowski, Sara Carazo Perez, Mamoudou N Conde, Jean-Luc Gala, Joseph Akoi Bore, Caroline Carbonnelle, Frédéric Jacquot, Hervé Raoul, Denis Malvy, Xavier Nicolas de Lamballerie, France Mentré, null null
Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targeted. PLoS neglected tropical diseases 11 (2) (2017)